# Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients

> **NCT03611985** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Epidiferphane
- **DRUG:** Taxane Chemotherapy

## Key facts

- **NCT ID:** NCT03611985
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** institutional conflict of interest
- **Last updated:** 2020-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03611985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03611985, "Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03611985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*